Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS; Caffeine for Apnea of Prematurity (CAP) Trial Investigators.
Schmidt B, et al. Among authors: solimano a.
JAMA. 2012 Jan 18;307(3):275-82. doi: 10.1001/jama.2011.2024.
JAMA. 2012.
PMID: 22253394
Clinical Trial.